MHRAsafety guidance83% confidence
Guidance: Clinical trials for medicines: roles and responsibilities
Source: MHRA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as opioid treatment pharma companies.
Regulatory Analysis
Which professions can act as an investigator, training and experience expectations, provision of medical support and delegation of activities.
Supporting Context
- Therapeutic area
- Addiction · Opioids
- Sub-indication
- Pain
Related signal: University of Missouri-Columbia Launches Naloxone Training Initiative to Combat Opioid Overdoses